Podcasts about technical university

It's In the News.. a look at the top headlines and stories in the diabetes community. This week's top stories: It's World Diabetes Day and we have a LOT of news to get to! Daily oral insulin tested to prevent T1D, mothers and sons and a T1D link, stem cell updates, Tandem Android news, Omnipod's workplace campaign and more! Find out how to submit your Community Commercial Find out more about Moms' Night Out  Please visit our Sponsors & Partners - they help make the show possible! Learn more about Gvoke Glucagon Gvoke HypoPen® (glucagon injection): Glucagon Injection For Very Low Blood Sugar (gvokeglucagon.com) Omnipod - Simplify Life Learn about Dexcom   Check out VIVI Cap to protect your insulin from extreme temperatures The best way to keep up with Stacey and the show is by signing up for our weekly newsletter: Sign up for our newsletter here Here's where to find us: Facebook (Group) Facebook (Page) Instagram Twitter Check out Stacey's books! Learn more about everything at our home page www.diabetes-connections.com  Reach out with questions or comments: info@diabetes-connections.com Episode transcription with links:   Hello and welcome to Diabetes Connections In the News! I'm Stacey Simms and every other Friday I bring you a short episode with the top diabetes stories and headlines happening now. It's world diabetes day! It is marked every year on 14 November, the birthday of Sir Frederick Banting, who co-discovered insulin along with Charles Best in 1922.   WDD was created in 1991 by International Diabetes Federation (IDF) and the World Health Organization and became an official United Nations Day in 2006 with the passage of United Nations Resolution 61/225. There will be a ton of stuff in your feeds today and that's great! I'm going to keep this to a pretty normal in the news episode.. although I do have my own World Diabetes Day announcement – I want YOUR community commercials. You could have an ad for your event or your blog or your project right here! There's a post on the website explaining it all and I'll come back at the end of the episode and tell you more. XX The Primary Oral Insulin Trial (POInT) is the first large-scale clinical trial to test whether giving at-risk children daily oral insulin could prevent or delay type 1 diabetes (T1D). Conducted by researchers from Helmholtz Munich and the Technical University of Munich across five European countries, the study enrolled more than 1,000 children with a genetic risk for T1D. Results published in The Lancet show that while oral insulin did not prevent the development of islet autoantibodies—an early sign of diabetes—it was safe and well tolerated. Importantly, researchers found that some children who received oral insulin developed diabetes more slowly than those given a placebo, suggesting potential protective effects in certain genetic subgroups.   Further analysis revealed that the response to treatment depended on the child's insulin gene variant. Children with genetic versions that raise diabetes risk appeared to benefit, showing delayed onset of the disease, while those without the risk variant did not. These findings point toward a future of personalized prevention, where genetic screening could help identify which children might benefit most from oral insulin. Researchers will continue following the participants until age 12 to assess long-term effects. The study marks a major milestone in decades of diabetes prevention research, highlighting both the promise and complexity of developing tailored, early interventions against type 1 diabetes. XX Joint US-Chinese research looking at generating new beta cells from stomach cells. Upon turning on the "genetic switch," the human stomach cells were converted to insulin-secreting cells within the mice and resembled pancreatic beta cells with respect to gene and protein expression. Encouragingly, when those experiments were done with diabetic mice, insulin secreted from the transformed human cells helped control blood sugar levels and ameliorated diabetes. The scientists hope that a similar approach can be taken to convert cells from a patient's own stomach into insulin-secreting cells directly within the body. Importantly, additional studies are needed to address if this approach is safe and effective to be used in patients. https://www.technologynetworks.com/cell-science/news/human-stomach-cells-tweaked-to-make-insulin-406694 XX A new study in Nature Metabolism may help explain why children born to mothers with type 1 diabetes are less likely to develop the disease early in life compared to those whose fathers or siblings have it. Researchers looked at nearly 2,000 mothers and their children and found that  kids whose moms have type 1 diabetes show changes in their DNA that may actually help protect them. These aren't genetic mutations, but epigenetic changes — chemical tags that turn certain genes on or off. The study found these changes in genes tied to the immune system and type 1 diabetes risk, suggesting that a mother's condition during pregnancy can shape her child's immune response in a protective way. Scientists identified more than 500 areas of DNA where these changes occurred, many in regions that control how the body's immune system works. Most of the changes appeared to calm down the kind of overactive immune response that leads to type 1 diabetes. Researchers even created a "methylation score" to help measure this protective effect. They say the next step is to confirm these results in more diverse groups and figure out exactly how these DNA changes help prevent early diabetes. https://www.news-medical.net/news/20251110/Maternal-type-1-diabetes-may-protect-children-from-developing-the-disease.aspx XX A new study from Karolinska Institutet and Stockholm University reveals that sons born to mothers with type 1 diabetes may develop early vascular dysfunction—independently of metabolic health. The finding may help shape future strategies to prevent cardiovascular disease early in life.     Children of women with type 1 diabetes are known to be at increased risk of developing cardiovascular diseases. This new study, published in Cell Reports Medicine, is the first to show that the risk is linked to early dysfunction in blood vessel cells in sons, even before any metabolic issues arise. The team is now investigating the long-term effects of maternal diabetes, with a particular focus on why sons seem to be affected earlier than daughters. https://medicalxpress.com/news/2025-11-sons-mothers-diabetes-early-vascular.html XX A new study presented at Kidney Week 2025 has shown that the drug finn-uh-near-own  a nonsteroidal mineralocorticoid-receptor antagonist, significantly reduced albuminuria—a key marker of kidney damage—in people with type 1 diabetes (T1D) and chronic kidney disease (CKD). This is the first major breakthrough for this population in more than 30 years. Researchers found that patients taking finerenone saw a 25% average reduction in albuminuria compared to placebo, an improvement that suggests a lower long-term risk for dialysis or kidney transplant. The phase 3 FINE-ONE trial involved 242 adults with T1D and CKD, and results showed benefits as early as three months. The drug was generally well tolerated, with side effects similar to those seen in patients with type 2 diabetes, though mild hyperkalemia (high potassium levels) was slightly more common. Experts say the findings could change the way doctors treat kidney complications in type 1 diabetes, an area that hasn't seen new therapies since the early 1990s. Currently, treatment options rely on blood pressure and blood sugar management, along with renin-angiotensin system (RAS) inhibitors. Finerenone, which is already approved for type 2 diabetes-related CKD, targets overactivation of a receptor that drives kidney damage. Based on these results, Bayer plans to seek FDA approval in 2026 for use in people with T1D and CKD. Researchers and clinicians alike are calling the study "groundbreaking," noting that it opens the door to future research on how finerenone might not just slow kidney decline—but possibly prevent it altogether. https://www.medscape.com/viewarticle/finerenone-offers-hope-kidney-disease-type-1-diabetes-2025a1000uzi?form=login   XX This week, Tandem Diabetes Care (Nasdaq:TNDM) announced a major milestone for its Mobi miniature durable insulin pump system. San Diego-based Tandem revealed that it received FDA approval for the Android version of its Mobi mobile app. Clearance brings Mobi — which the company describes as the world's smallest, durable automated insulin delivery system — to more users. The pump, which pairs with Tandem's Control-IQ+ algorithm, previously worked with iOS software.   Tandem — one of the largest diabetes tech companies in the world — expects to begin a limited rollout next month, followed by full commercial availability in early 2026. This marks the latest milestone for the company, which continues to expand its offerings and widen its reach within the diabetes patient population.   We had a great interview with Tandem on our previous episode, but as I said at the time, it was coming before their earnings call. So here's an update: The company plans to submit the tubeless mobi to the fda before the end of this year.. possible approval and shipping date is hoped for by middle of 2026. Trials for their fully closed loop next-generation algorithm which we tlkaed abou ton the show should be launched in 2026 The Sigi patch pump will be developed and launched as a next-generation version of the Mobi Great job by Dr. David ? Ahn – he posted on IG after getting a message from tandem CEO John Sheridan? 1. First, the Tandem X3 *is* still absolutely in development, contrary to my speculation In yesterday's video. As many of you appropriately pointed out, there is definitely a market for a 300 unit pump, a pump with a screen, and a pump that does not require smartphone control. So from our brief chat, the sense I got that is that the X3 would be more of a refresh of the X2 with newer components, such as a USB-C connector and better memory, rather than a total redesign from the ground up. In terms of timing, all I could get was that it was "not too far distant in the future," which could mean anything I guess, but at least it's still on the way! 2. Next up, he also reassured me that they are working closely with Dexcom to support the G7 15 Day sensor within the next few months. I suspected as much, but it's always good to hear confirmation. 3. Lastly, he did confirm that Tandem is far along in developing a Caregiver/Follow app to allow the remote viewing of glucose and insulin data from a Tandem pump. He explained that it will be based on Sugarmate, the popular diabetes data dashboard app that Tandem acquired back in Jun 2020. While I don't know if every feature will make it into the Tandem caregiver app, Sugarmate is well-liked for its highly customizable dashboard and highly configurable alerts. Sugarmate even has the option to send a text message or phone call for urgent lows. Regardless, a true follow/Caregiver app will be welcomed with open arms by all caregivers and Tandem users who use Libre 3 Plus. https://time.com/7318020/worlds-top-healthtech-companies-2025/ XX Senseonics submits Eversense 365 – their year long implantable CGM for a CE mark, European Approval and expect to launch there soon. Eversense will be integrated with the sequel twist pump – again I'm hearing soon but no timeline. Intersting to note that one year inseration was approved in the US just about a year ago, so the first patients will be having their CGMs changed out – for the first time – pretty soon. https://www.drugdeliverybusiness.com/senseonics-q2-2025-sales-beat-ce-mark/ XX A confusing study out of Rutgers - these researcher say  metformin reduces some of the key benefits normally gained from regular physical activity. These include improvements in blood vessel health, physical fitness, and the body's ability to regulate blood sugar. Since 2006, doctors have typically encouraged patients with elevated blood sugar levels to combine metformin with exercise, expecting that the two proven treatments would produce stronger results together. However, the new research suggests this may not be the case. In this study, Exercise alone improved vascular insulin sensitivity, meaning blood vessels responded better to insulin and allowed more blood flow to muscles. This matters because insulin's ability to open blood vessels helps shuttle glucose out of the bloodstream and into tissues, lowering blood sugar after meals. But when metformin was added, the improvements shrank. The drug also diminished gains in aerobic fitness and reduced the positive effects on inflammation and fasting glucose. The findings don't mean people should stop taking metformin or exercising, Malin said. Instead, it raises urgent questions for doctors about how the two treatments can be combined and the need for close monitoring. Malin hopes future research will uncover strategies that preserve the benefits of both. https://scitechdaily.com/popular-diabetes-drug-metformin-may-cancel-out-exercise-benefits-study-warns/ XX XX https://www.medtechdive.com/news/Revvity-Sanofi-diabetes-test-Kihealth-seed-round/802133/   XX Dexcom recalled an Android app for its G6 glucose sensor due to a software problem that could cause the app to terminate unexpectedly. The issue could cause users to miss alarms, alerts or notifications related to estimated glucose values, according to a Food and Drug Administration database entry posted Oct. 30. The glucose sensor and the app are still available, but Dexcom required users to update the app to a new version. Dexcom began the recall on Aug. 28. The FDA designated the event as a Class 1 recall, the most serious kind. Dexcom sent a notification to customers in September about the software bug, which applies to version 1.15 of the G6 Android app. To use the app, customers must update it to a new version, according to the entry. https://www.medtechdive.com/news/dexcom-recall-g6-cgm-app/804630/ XX https://www.medscape.com/viewarticle/automated-insulin-delivery-boosts-glycemic-control-youth-2025a1000ub3 XX Tidepool partners with smart ring maker OURA.. press release says: to support a groundbreaking dataset intended to be broadly available for diabetes research, with participation limited to individuals who opt in through Tidepool.         Tidepool will pair biometric data from Oura Ring – sleep, activity, heart rate, temperature trends, and menstrual cycles – with diabetes device data, including continuous glucose monitors (CGMs) and insulin pumps. The result will provide researchers with an unprecedented dataset to accelerate the development of new clinical guidelines, next-generation diabetes technology, and personalized care models.   Recruitment is expected to launch in early 2026 through an IRB-approved study. By opting in to this study, participants consent to sharing their data with Tidepool's Big Data Donation Project, where data is de-identified and, with participant consent, shared with academics, researchers, and industry innovators to accelerate diabetes research. https://aijourn.com/tidepool-collaborates-with-oura-to-advance-inclusive-diabetes-research-through-wearables/ XX Eli Lilly launches two new clinical trials for baricitinib. These phase 3 trials will investigate whether the drug can delay T1D onset or progression and will open for recruitment soon. Baricitinib has the potential to extend the "honeymoon period" of T1D, meaning that it could preserve remaining insulin-producing beta cells earlier in disease progression. More beta cells mean better blood sugar management—and potentially reduced long-term complications. JAK inhibitors, including baricitinib, are already FDA-approved for other autoimmune diseases, such as rheumatoid arthritis, alopecia, and more. JAK signaling pathways are associated with overactive immune responses, so blocking this pathway may turn down the immune response. The phase 2 Breakthrough T1D-funded BANDIT study was key in showing that this drug is safe and effective in T1D. Importantly, baricitinib is a once-daily oral pill—meaning its use is simple and easy.   https://www.breakthrought1d.org/news-and-updates/two-new-trials-baricitinib-to-delay-t1d/ XX   Insulet is taking diabetes awareness into the workplace. Having found 79% of people with diabetes have faced bias or misunderstanding at work, the medtech giant is rolling out a range of resources intended to trigger changes in how workplaces approach the condition. Lots going on for Diabetes Awareness month.. some notables.. Insulet's "The Day Diabetes Showed up to Work" campaign. based on a survey of almost 10,000 people 79% of people with diabetes have faced bias or misunderstanding at work,.   Almost 90% of people with diabetes surveyed reported experiencing barriers at work due to their condition, and more than 40% of people with diabetes and caregivers said they have workplace-related anxiety tied to the metabolic disease. Around one-quarter of respondents reported fears that diabetes could limit opportunities or lead to workplace discrimination and judgment, and a similar proportion of people said they conceal their condition. https://www.fiercepharma.com/marketing/widespread-workplace-challenges-people-diabetes-spark-insulet-campaign XX New directive issued by the Trump administration could mean people seeking visas to live in the U.S. might be rejected if they have certain medical conditions, including diabetes or obesity.   The guidance, issued in a cable the State Department sent to embassy and consular officials and examined by KFF Health News, directs visa officers to deem applicants ineligible to enter the U.S. for several new reasons, including age or the likelihood they might rely on public benefits.   The guidance says that such people could become a "public charge" — a potential drain on U.S. resources — because of their health issues or age.   The cable's language appears at odds with the Foreign Affairs Manual, the State Department's own handbook, which says that visa officers cannot reject an application based on "what if" scenarios, Wheeler said.   The guidance directs visa officers to develop "their own thoughts about what could lead to some sort of medical emergency or sort of medical costs in the future," he said. "That's troubling because they're not medically trained, they have no experience in this area, and they shouldn't be making projections based on their own personal knowledge or bias."   Immigrants already undergo a medical exam by a physician who's been approved by a U.S. embassy. https://www.npr.org/2025/11/12/nx-s1-5606348/immigrants-visas-health-conditions-trump-guidance XX SAN DIEGO---Nov. 14, 2025—DexCom, Inc. (NASDAQ: DXCM), the global leader in glucose biosensing, today unveiled 16 new diabetes advocates to represent people living with diabetes globally as part of Dexcom's World Diabetes Day campaign. The advocates – ranging from ages six to 68, spanning various types of diabetes, and hailing from four continents and five countries – were selected from 1,000 open call submissions based on their experiences advocating for people with diabetes in their communities. While each person's experience with diabetes is unique, they share a common passion for advocacy – and use of Dexcom's glucose biosensing technology. "Through advocacy, I strive to show others, especially children and newly diagnosed patients, that diabetes is not a limitation but an opportunity to grow stronger, inspire resilience and pursue ambitious goals," said Maria Alejandra Jove Valerio, one of Dexcom's new advocates. "What began as a diagnosis at age seven has grown into a lifelong mission to uplift others." This effort represents the first time Dexcom has sourced voices from the broader diabetes community specifically for its World Diabetes Day campaign, reinforcing Dexcom's history of and commitment to giving real people with diabetes a platform to share their story on a global stage. Through engaging, editorial-style portraits and deeply personal stories, the campaign highlights each advocate's personal experience with diabetes, what misconceptions about diabetes they'd like to dispel and how they want to inspire others with diabetes to discover what they're made of. To prepare for the spotlight, the group of advocates met in Los Angeles for a World Diabetes Day photoshoot which included a surprise visit from Grammy-nominated artist, actor, producer and Dexcom Warrior Lance Bass and author, producer, actress and Stelo*Ambassador Retta. This visit offered the advocates an opportunity to exchange stories and personal perspectives on the meaning of diabetes advocacy and how they live it each day. Behind the lens at the shoot was another member of the diabetes community—photographer Tommy Lundberg who lives with Type 1 diabetes. "Directing this photoshoot was nothing short of inspiring. Each of these advocates has a unique an XX On what would have been the 100th birthday of its visionary founder Alfred E. Mann, MannKind Corporation (Nasdaq: MNKD), in partnership with Alfred E. Mann Charities and The Diabetes Link, announced the launch of the Centennial Al Mann Scholarship. The new program will distribute $100,000 in scholarship funds to support at least 10 young adult students living with diabetes as they pursue higher education in life sciences.   Launched in Diabetes Awareness Month, the scholarship program honors Alfred E. Mann's enduring legacy of innovation, philanthropy, and his lifelong commitment to improving the quality of human life through medical advancement. Deeply passionate about giving back, Mr. Mann believed that his success should continue to serve humanity long after his passing, a belief that lives on through this initiative.   Each scholarship recipient will be awarded up to $10,000, distributed in annual installments of $2,500 throughout the course of their studies. Depending on the length of their degree program, recipients may receive between two and four installments (up to the full $10,000 per student). The first awards will be made for the 2026 academic year.   "Al Mann dedicated his life to helping people with serious medical conditions live longer, healthier lives. This scholarship is a reflection of that spirit," said Michael Castagna, PharmD, Chief Executive Officer of MannKind Corporation. "By supporting students living with diabetes who are pursuing careers in the life sciences and adjacent fields, we're honoring Al's legacy and investing in the future of innovation and care. This program is about giving back to the community we serve and empowering the next generation to carry forward Al's mission of making a meaningful difference in people's lives."   Alfred E. Mann Charities and MannKind will partner with The Diabetes Link to launch the program to serve young adults (aged 18-22) living with either type 1 or type 2 diabetes with their higher education goals. Those eligible will include incoming freshmen and current students pursuing 2- or 4-year degrees. The application window will open in early 2026, and for those interested in receiving notifications, an early interest form is available. More information about the scholarship will be shared on thediabeteslink.org.   "We're honored to partner with MannKind to expand access to higher education for young adults with diabetes," said Manuel Hernández, Chief Executive Officer of The Diabetes Link. "At a time when the cost of college continues to rise, this scholarship helps ease the financial burden and carries forward the spirit of Al Mann, whose vision and legacy continue to inspire us."   Mr. Mann was MannKind's Chairman of the Board from 2001 until his passing in February 2016 and served as Chief Executive Officer from November 2003 until January 2015. Driven by a desire to improve lives and fill unmet medical needs, for more than six decades he founded 17 companies and developed breakthrough medical devices, including insulin pumps, cochlear implants, cardiac pacemakers and retinal prostheses. In 1997, Mr. Mann saw the potential of a dry powder insulin formulation to change the way diabetes is treated and invested nearly $1 billion to help bring Afrezza® (insulin human) Inhalation Powder to market.   About MannKind MannKind Corporation (Nasdaq: MNKD) is a biopharmaceutical company dedicated to transforming chronic disease care through innovative, patient-centric solutions. Focused on cardiometabolic and orphan lung diseases, we develop and commercialize treatments that address serious unmet medical needs, including diabetes, pulmonary hypertension, and fluid overload in heart failure and chronic kidney disease.   With deep expertise in drug-device combinations, MannKind aims to deliver therapies designed to fit seamlessly into daily life.   Learn more at mannkindcorp.com.   About Alfred E. Mann Charities, Inc. Alfred E. Mann Charities, Inc. became active in 2016, following the passing of the organization's benefactor, Alfred E. Mann. Throughout his life, Al was passionate about philanthropy and was dedicated to prolonging and improving the quality of human lives through innovation in the fields of healthcare and the use of medical devices. It was important to Al that his success and assets continue to better human lives even after his own passing.   Alfred E. Mann Charities, Inc. (formerly known as Alfred E. Mann Family Foundation) has similarly placed its primary focus on healthcare and medical innovation, as our organization believes this is where we can have the greatest impact on humanity and human health throughout the world. Alfred E. Mann Charities, Inc. is also dedicated to promoting arts, culture, education, and community development across Los Angeles and throughout the world in order to best serve people and this planet.   Learn more at aemanncharities.org.   About The Diabetes Link The Diabetes Link is the only national nonprofit organization dedicated to empowering young adults living with diabetes. Founded by and for young adults, The Link serves this community through peer support, leadership opportunities, and practical, evidence-based resources designed for real life. Its network of campus and community chapters, active online community, and robust Resource Hub help young adults navigate the transitions of early adulthood while managing diabetes. The organization envisions a future where every young adult living with diabetes has

What is building a large scale battery-powered aircraft was more feasible than originally thought?Our guest on this episode of the podcast, Daniel Rosen Jacobson co-founder and co-CEO of Elysian Aircraft, has come on the podcast to explain how asking the right questions and conducting scientific research laid the groundwork for the truly ambitious project that is the E9X electric airliner.While most electric aircraft projects have focused on the development of smaller aircraft, Elysian Aircraft is taking on the mainstream air travel market with a zero-emissions aircraft concept capable of carrying up to 90 passengers over distances of 1,000 kilometers.This is certainly a bold proposition, but one that, Daniel explains, is well grounded in science and engineering principles laid out by two papers co-authored by researchers at the Technical University of Delft, in The Netherlands.What's more, Elysian Aircraft is backed by Panta Holdings, a company that is no strangers to the world of aviation since it is the owner of Fokker Services Group, which is the remaining part of the iconic Dutch aircraft maker of the same name, now providing a range of MRO and other technical services to aircraft operators. Elysian's take on the future of zero emissions aircraft has also attracted the interest of consolidated industry players such as the Air France-KLM group and leasing firm TrueNoord, both of which have signed collaboration agreements with Elysian Aircraft with a view to potentially using the E9X aircraft one day in the future.This will, for now, have to wait a few years, as Elysian Aircraft refines its concept and builds and tests its first prototypes. In the meantime, though, we can listen to Elysian Aircraft's co-founder and co-CEO, Daniel Rosen Jacobson, explaining the key elements of this projected aircraft and the role he expects it to play in the future of commercial aviation!

In this episode, we sit down with Dr. Alicia Hennig, interim professor of business ethics at the Technical University of Dresden in Germany, who brings extensive professional experience in China from both business and academia. Dr. Hennig guides us through understanding China's political system, exploring the role of the Chinese Communist Party in daily life and the philosophical foundations that shape Chinese political thought—and how these differ fundamentally from Western traditions. She discusses Xi Jinping's transformation of China, including the expansion of surveillance systems and what this means for ordinary citizens. Dr. Hennig also addresses common Western blind spots, notably how Beijing views itself on the world stage following its "century of humiliation." We explore the top concerns of the CCP leadership, how China perceives America and the West, and the fundamental differences between Chinese and Russian authoritarian visions for the 21st century. Finally, Dr. Hennig discusses the "no-limits partnership" between China and Russia amid the Ukraine war and offers insights into what Canadians should be watching regarding China in the months ahead.

In this episode, I reconnect with Prof. Ruth Oldenziel from the Technical University in Eindhoven for a discussion about the global Cycling Cities Initiative, which kicked off in 2016 with the publication  of the Cycling Cities: The European Experience coffee table book, which I happen to have in my house. We talk about the maturation of the project, including the upcoming release of the Cycling Cities: The African Experience, as well as the first from North America, Minneapolis. Helpful Links (note that some may include affiliate links to help me support the channel):

In this episode, we speak with Ashmi Banerjee, a doctoral candidate at the Technical University of Munich, about her pioneering research on AI-powered recommender systems in tourism. Ashmi illuminates how these systems can address exposure bias while promoting more sustainable tourism practices through innovative approaches to data acquisition and algorithm design.  Key highlights include leveraging large language models for synthetic data generation, developing recommendation architectures that balance user satisfaction with environmental concerns, and creating frameworks that distribute tourism more equitably across destinations. Ashmi's insights offer valuable perspectives for both AI researchers and tourism industry professionals seeking to implement more responsible recommendation technologies.

BUFFALO, NY — October 7, 2025 — A new #research paper was #published in Volume 17, Issue 9 of Aging-US on August 27, 2025, titled, “Deregulated miR-145 and miR-27b in Hutchinson-Gilford progeria syndrome: implications for adipogenesis.” In this study, led by first author Felix Quirin Fenzl and corresponding author Karima Djabali from the Technical University of Munich (TUM), researchers identified that miR-145-5p and miR-27b-3p interfere with the formation of fat cells in children with Hutchinson-Gilford progeria syndrome (HGPS), a rare and fatal premature aging disorder. Their findings help explain why patients often experience fat loss and related metabolic complications and suggest new potential therapeutic strategies. Hutchinson-Gilford progeria syndrome is a genetic condition that causes rapid aging in children, often leading to early death due to heart disease. Although affected children appear healthy at birth, they soon develop signs of accelerated aging, including hair loss, stiff joints, and a significant reduction in fat tissue. While certain treatments can slow disease progression, many aspects, such as the loss of fat tissue, remain poorly understood. “Overall, this study provides the first comprehensive miRNA profiling of HGPS and control fibroblasts across different stages of cellular senescence.” This study focused on how microRNAs—tiny molecules that help regulate gene expression—contribute to the disease. To explore this, the researchers used skin-derived stem cells from both healthy individuals and HGPS patients. When they transformed these cells into fat cells, the HGPS-derived stem cells formed significantly fewer fat cells. This difference was linked to unusually high levels of miR-145-5p and miR-27b-3p. These molecules were found to silence important genes required for fat cell growth and function. When the researchers blocked these microRNAs, fat cell formation improved. The team also examined fat tissue from a mouse model of HGPS. Similar to the human cells, these mice showed increased levels of miR-145-5p and miR-27b-3p and impaired fat development. These results confirm that these two microRNAs play a central role in the loss of fat tissue seen in the disease. Importantly, reducing their activity could become a promising therapeutic strategy for restoring fat tissue in affected individuals. Although further research is needed before developing treatments, this study represents a step forward in understanding the molecular causes of lipodystrophy, a condition in which the body cannot form healthy fat tissue, in HGPS. It also opens the door for future therapies that could improve quality of life and health outcomes for patients. In the long term, similar approaches might benefit people with other metabolic diseases, such as obesity or diabetes, where fat cell function is also disrupted. DOI - https://doi.org/10.18632/aging.206309 Corresponding authors - Karima Djabali — djabali@tum.de Abstract video - https://www.youtube.com/watch?v=b0ksC3cvdZ0 Sign up for free Altmetric alerts about this article - https://aging.altmetric.com/details/email_updates?id=10.18632%2Faging.206309 Subscribe for free publication alerts from Aging - https://www.aging-us.com/subscribe-to-toc-alerts Keywords - aging, Hutchinson-Gilford progeria syndrome (HGPS), progerin, microRNAs, adipogenesis To learn more about the journal, please visit our website at https://www.Aging-US.com​​ and connect with us on social media at: Facebook - https://www.facebook.com/AgingUS/ X - https://twitter.com/AgingJrnl Instagram - https://www.instagram.com/agingjrnl/ YouTube - https://www.youtube.com/@AgingJournal LinkedIn - https://www.linkedin.com/company/aging/ Bluesky - https://bsky.app/profile/aging-us.bsky.social Pinterest - https://www.pinterest.com/AgingUS/ Spotify - https://open.spotify.com/show/1X4HQQgegjReaf6Mozn6Mc MEDIA@IMPACTJOURNALS.COM

In this episode of Molecule to Market, you'll go inside the outsourcing space of the global drug development sector with Lars Petersen, President & Chief Executive Officer at FUJIFILM Biotechnologies.   Your host, Raman Sehgal, discusses the pharmaceutical and biotechnology supply chain with Lars, covering: The difficult decision to leave Novo Nordisk and make the jump from one great company to another in Genentech/Roche. How leaving a Biogen site led him to step away from big pharma after 25 years and transition to the CDMO side. How Fujifilm's culture of innovation, technology, quality, and people runs through the Biotechnologies division — and why empowerment and culture should never be compromised. Why the duplication of its CDMO sites globally, all running on the same kojoX platform, is truly differentiating. Why he believes the need to standardise, scale, and globalise drug production in a consistent, efficient, and traceable way is key to the future of the supply chain. Molecule to Market is also sponsored by Bora Pharma (boracdmo.com) and Charles River (www.criver.com), and supported by Lead Candidate.    Lars Petersen, CEO of FUJIFILM Biotechnologies, is recognized as a visionary leader in the life science sector, commanding a global contract development and manufacturing organization (CDMO) with nearly 5,000 employees spread across Denmark, UK, USA, and Japan.    Distinguished for his strategic vision and a "people first" philosophy, Lars has profoundly impacted the company and the industry. His leadership journey saw him rise from Chief Operational Officer & Senior Vice President at the Danish site, where he established an empowering culture, to CEO, promoting transparency across all operations. Since his global leadership appointment in June 2023, Lars has been instrumental in cultural transformation, integrating a "people first" approach across FUJIFILM Biotechnologies' global facilities regardless of geographical differences.   Prior to his appointment as CEO, Lars was responsible for the Global Large Scale Commercial operation including full profit and loss accountability as well as the responsibility for over $6.2 Billion global expansions both in Hillerød, Denmark, and Holly Springs, North Carolina, USA.   Previously, Lars has held leadership positions with Biogen, Genentech/Roche, Novo Nordisk, Novozymes and NNE, and he has successfully executed projects in Europe, China and the US.   Lars holds a master's degree from the Technical University of Denmark.   Please subscribe, tell your industry colleagues and join us in celebrating and promoting the value and importance of the global life science outsourcing space. We'd also appreciate a positive rating! 

Are you a night owl or a morning lark?For many of us the traditional working day just doesn't suit our circadian rhythms. We're called into a meeting or slumped over a desk at 8am but hyper focused as we're about to leave the office and head home. What if work took our biological clocks into account?In this episode I am joined by Camilla Kring, author of Chrono leadership. We talk about the costs of rigidity in work patterns, and what it takes to develop smarter, more flexible arrangements.Camilla's ideas are revolutionary; she talks about taking the bias away from the 5am club and creating better conditions in the workplace for all. Surely that is something we would all want to get behind.So, when do you perform at your best during the day?“Synchronise your work, family, and biological rhythms for real performance.” - CamillaYou'll hear about:·      How circadian rhythms dictate our natural sleep and wake cycles.·      Why understanding your chronotype can enhance productivity.·      The fact most people are not morning persons, yet workplaces favour early risers.·      How living out of sync with your internal clock can harm health.·      Flexibility in work hours can lead to higher productivity and well-being.·      Trust in employees being crucial for implementing flexible work schedules.·      Why synchronising work and family rhythms can improve life quality. More about Camilla:Camilla Kring, as the founder of Super Navigators, has dedicated the last 20 years to helping individuals navigate their lives and organisations create flexible and inclusive work cultures that accommodate different chronotypes and family structures. She has worked across Europe, China, Latin America and the Middle East with companies including Abbott, Medtronic, Roche and Novo Nordisk.Camilla's insights have been featured in the New York Times, the BBC and the Guardian. She is the author of six books and a TEDx speaker. She holds a Master of Science in Engineering and a PhD in work-life balance from the Technical University of Denmark (DTU). Resources:• Profile: https://www.camillakring.com/about-camilla/ • Book - Chronoleadership: https://www.camillakring.com/books/ • Supernavigators services: https://www.supernavigators.com/   My resources:Try my High-stakes meetings toolkit (https://bit.ly/43cnhnQ) Take my Becoming a Strategic Leader course (https://bit.ly/3KJYDTj)Sign up to my Every Day is a Strategy Day newsletter (http://bit.ly/36WRpri) for modern mindsets and practices to help you get ahead.Subscribe to my YouTube channel (http://bit.ly/3cFGk1k) where you can watch the conversation.For more details about me:●      Services (https://rb.gy/ahlcuy) to CEOs, entrepreneurs and professionals.●      About me (https://rb.gy/dvmg9n) - my background, experience and philosophy.●      Examples of my writing https://rb.gy/jlbdds)●      Follow me and engage with me on LinkedIn (https://bit.ly/2Z2PexP)●      Follow me and engage with me on Twitter (https://bit.ly/36XavNI)

What defines a megaproject? And why do they so often go over both budget and schedule?   Denmark has earned a reputation for successfully completing large-scale construction projects – whether they are bridges, tunnels, land reclamation or offshore wind farms. The latest Danish megaproject is the Fehmarnbelt Fixed Link, a record-breaking 18-kilometer tunnel currently being placed on the seabed from the island of Lolland to Northern Germany.  In this episode, Michael Booth joins Professor Christian Langhoff Thuesen of Denmark's Technical University on a visit to the construction site of the Fehmarnbelt Fixed Link. Together they explore the impressive scale of the project and discuss the future of megaprojects in light of growing sustainability demands.   Let's Talk Architecture is a podcast by Danish Architecture Center. Sound edits by Munck Studios. 

In this episode of Molecule to Market, you'll go inside the outsourcing space of the global drug development sector with Michael Scholl, Chief Executive Officer and Co-Founder at Leukocare. Your host, Raman Sehgal, discusses the pharmaceutical and biotechnology supply chain with Michael, covering: The influences, and potential for impact that led him down a path of entrepreneurship. Chronicling the ups and downs of over 20 years in business at Leukocare. Pivoting to be a specialist CRO/CDMO with a differentiation in data-driven, formulation development... leading to a record year in 2024. How the delay in decision making in the market is impacting the pharma services space. Michael Scholl is the Co-founder and Chief Executive Officer of Leukocare, a leading CDMO specializing in formulation and drug product development services for sterile injectables. With more than 20 years of leadership experience in the life sciences industry, Michael is responsible for shaping the company's strategic direction and cultivating partnerships with biopharmaceutical clients around the world. Under his leadership, Leukocare has established itself as a trusted partner in advancing complex biologics from early development to market-ready drug products. He began his career as a business consultant at the Boston Consulting Group (BCG), he holds a degree in Industrial Engineering from the Technical University of Berlin and studied at the Haas School of Business, University of California, Berkeley.   Molecule to Market is also sponsored by Bora Pharma (boracdmo.com) and Charles River (www.criver.com), and supported by ramarketing.   Please subscribe, tell your industry colleagues and join us in celebrating and promoting the value and importance of the global life science outsourcing space. We'd also appreciate a positive rating!

What does the future of hospitality look like in an era of AI, personalization, loyalty and sustainability? And how can providers keep pace with rising guest expectations?In this special episode of dojo.live, we sat down with Paco Pérez-Lozao Rüter, President of Hospitality at Amadeus IT Group, during the company's media event in New York City. The conversation unpacks insights from Amadeus' latest global research report, Connected Journeys: How will technology transform travel in the next decade? and explores what it all means for the future of hospitality.From the role of generative AI in shaping inspiration, search, and booking to the evolving power of hotel loyalty programs, Paco shares a forward-looking perspective on how technology is reshaping the guest journey. We discuss why disruption management is emerging as a true competitive differentiator, where automation must be balanced with the human touch, and how hoteliers can leverage modern retailing and personalization while safeguarding traveler privacy.The conversation also touches on sustainability, industry-wide tech gaps, and the pace of adoption—highlighting the opportunities and challenges that lie ahead as hospitality providers move from “crawl” to “run” mode. Packed with data and insights from Amadeus' research, this episode offers a clear-eyed view of how travel is evolving and what hospitality leaders need to know to stay ahead.About Paco Pérez-LozaoPaco Pérez-Lozao leads Amadeus' global Hospitality business since 2018, including its Destinations line, overseeing tech solutions that help hotels and destination organizations grow, optimize operations, and elevate the traveler experience. Since spearheading the creation of the Hospitality business unit in Amadeus, he has played a key role in positioning Amadeus as a trusted technology partner across the hospitality and travel ecosystem.A seasoned executive with over 30 years in travel technology, Paco has held senior roles in Commercial, Corporate Strategy, M&As, and Business Development at Amadeus, contributing to the company's diversification and expansion into new markets. He previously led the Strategic Growth Business Unit to support growth in key areas of the travel sector, such as Airport IT, Travel Intelligence, and Digital Payments. Some of these Amadeus businesses have evolved to become top players in their respective sectors.Paco began his career in consulting at Accenture and holds an MBA from INSEAD, along with two engineering degrees from the Technical University of Aachen, in Germany. He brings a global perspective and a deep understanding of the intersection between technology, travel, and investment.

Before CRISPR-based methods took center stage in the genome editing field, other bio-inspired tools such as zinc finger nucleases and Cre-lox system recombinases made genomic engineering possible. Some researchers are now looking back to these foundational technologies to improve upon and one-up the latest gene editing techniques.  In this episode, Deanna MacNeil from The Scientist spoke with Frank Buchholz, professor and head of the medical systems biology translational research group at the Technical University of Dresden's University Cancer Center, to explore how his laboratory designs programmable recombinases for high fidelity gene editing.   The Scientist Speaks is a podcast produced by The Scientist's Creative Services Team. Our podcast is by scientists and for scientists. We bring you the stories behind news-worthy molecular biology research. This episode is brought to you by Oxford Nanopore.

We speak with Andreas Hartl, Senior Vice President for the Asia-Pacific and Japan (APJ) region at Zscaler. Andreas is responsible for driving the company's growth and strategic initiatives across the region.Prior to joining Zscaler, Andreas held senior leadership positions at several leading technology companies, including Aveva, IBM & Microsoft, where he played a pivotal role in expanding market presence and achieving significant revenue growth. His extensive background in sales, business development, and strategic planning has equipped him with a deep understanding of the APJ market and its unique opportunities.Andreas is known for his ability to build and lead high-performing teams, fostering a culture of innovation and customer-centricity. His strategic vision and execution have been instrumental in driving Zscaler's success in the region, helping organizations securely transform their digital infrastructure.He holds a Bachelor's in Applied Sciences, Electrical Engineering & Information Technology from Technical University of Munich as well as a Master's from University of Applied Sciences Munich. With a strong commitment to excellence and a forward-thinking mindset, Andreas Hartl continues to shape the future of secure digital transformation in the APJ region.#ZL2025 #zerotrustsecurity #mysecuritytv #zscaler

Timestamps:8:30 - The problem in VA that CREAL is tackling15:10 - VA as the future 34:45 - What's next for CREAL after closing another funding round46:45 - Why don't we see more Swiss startups becoming global category leaders? This episode was co-produced by SICTIC, the leading angel investor network in Switzerland.Click ⁠⁠⁠here⁠⁠⁠ to order your copy of “Swiss Startups” today.Episode Summary:Bolko Hohaus is the Founder & CEO of HCP Asset Management, a Geneva-based investment boutique delivering performance-driven and innovative financial solutions. He holds a Ph.D. in Economics from LMU München. Tomas Sluka is the CEO & Co-Founder of CREAL, a Swiss deep-tech startup pioneering light-field displays for more natural and immersive Augmented Reality experiences. He holds a Ph.D. in Mechatronics Science and Engineering from the Technical University of Liberec.In their conversation with Silvan, Bolko and Tomas discuss the current challenges in AR, the disruptive potential of CREAL's technology, and why investing in startups can actually deliver stronger returns than traditional options.They also share their views on the Swiss startup ecosystem, why more Swiss companies don't grow into category leaders, and what's next for CREAL after closing their recent funding round.The cover portrait was edited by ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠www.smartportrait.io⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠.‍Don't forget to give us a follow on⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠ ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠Instagram⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠,⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠ ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠Linkedin⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠,⁠⁠⁠⁠⁠⁠ TikTok⁠⁠⁠⁠⁠⁠, and⁠⁠⁠⁠⁠⁠ Youtube ⁠⁠⁠⁠⁠⁠so you can always stay up to date with our latest initiatives. That way, there's no excuse for missing out on live shows, weekly giveaways or founders' dinners.

Iman Mossavat speaks with Professor Daniel Cremers, Director of the Munich Center for Machine Learning, Professor at the Technical University of Munich, and one of Germany's most distinguished AI researchers. Cremers is a recipient of the Gottfried Wilhelm Leibniz Prize and the 2024 ECCV Koenderink Test of Time Award.They discuss the groundbreaking work his team carried out in protein structure prediction back in 2016, years before AlphaFold made headlines. Although this work was presented at NeurIPS 2016, the flagship machine learning conference, in front of thousands of researchers, it was largely overlooked in subsequent citations.Beyond the science, Cremers reflects on the tension between academia and Big Tech, the challenges of recognition in a fast-moving field, and what it means to pursue meaningful work in AI today.

An interview with Merve Balaban, Project Manager & Systems Engineer for Berlin Space Consortium, a german space company focused on the development, manufacturing and testing of customized electric space propulsion systems.  Merve has bachelors and masters degrees in Aerospace Engineering from the Technical University in Berlin and is currently working on her doctorate degree from the university of Dresden in Germany.While  born and raised in Germany, her family is from Turkey and is involved in helping grow the aerospace ecosystem there while volunteering for organizations like Star Lab and the Space Generation Advisory Council.  She mentors students and young professionals interested in pursuing a career in the aerospace industry. Merve is currently lead for the Global Space Enablers Network (GSEN) Mentorship Program initiative.Hosts:  SpaceBase Founder Emeline Paat-DahlstromSupport the showSupport the show

How do you transform hybrid model digital twins from promising lab concepts into commercial bioprocessing game-changers that actually deliver ROI?As biotech companies race to implement Industry 4.0 technologies, the critical challenge isn't just developing sophisticated hybrid models - it's deploying them strategically to create user-friendly, cost-effective solutions that genuinely accelerate your path to commercial bioprocessing success.In Part 2 of this essential conversation, David Brühlmann continues his deep dive with Krist Gernaey, Professor of Industrial Fermentation Technology at the Technical University of Denmark. Krist reveals the strategic framework for moving beyond digital twin hype to build hybrid modeling capabilities that scale from lab validation to commercial manufacturing reality.Three Strategic Insights for Commercial Implementation:Digital Twins That Deliver Business Value: Krist cuts through the marketing buzz to define what makes digital twins commercially viable - revealing why true value comes from two-way data exchange and predictive capabilities, not just virtual process copies. Learn the validation strategies that separate successful implementations from expensive pilot projects.Modular Strategy Over Technology Complexity: Forget the "silver bullet" mentality. Krist advocates for strategic building blocks: start with site comparisons and predictive maintenance, then systematically add hybrid modeling complexity as your organization develops the technical capacity and team skills for sustainable commercial success.User-Centric Models for Operational Excellence: The biggest commercial wins aren't always about optimizing yields - they're about creating transparency, robust documentation, and operator-friendly tools that reduce complexity rather than adding it. Discover how to design hybrid model digital twins that empower your manufacturing teams instead of overwhelming them.Ready to develop a strategic roadmap for implementing hybrid model digital twins that drive commercial bioprocessing success? Tune in for Krist's proven framework for avoiding "cauliflower complexity" while building sustainable digital transformation capabilities that scale.Connect with Krist Gernaey:LinkedIn: www.linkedin.com/in/krist-gernaey-591748Website: www.orbit.dtu.dk/en/persons/krist-v-gernaeyIf you're intrigued by the evolving frontier of bioprocessing, don't miss these enlightening episodes:Episodes 85-86: Bioprocess 4.0: Integrated Continuous Biomanufacturing with Massimo MorbidelliEpisodes 153-154: The Future of Bioprocessing: Industry 4.0, Digital Twins, and Continuous Manufacturing Strategies with Tiago MatosEpisodes 05-06: Hybrid Modeling: The Key to Smarter Bioprocessing with Michael SokolovNext step:Book a free consultation to help you get started on any questions you may have about bioprocessing analytics: https://bruehlmann-consulting.com/callDevelop bioprocessing technologies better, faster, at a fraction of the cost with our 1:1 Strategy Call: The quickest and easiest way to excel biotech technology development. Book your call at https://stan.store/SmartBiotechSupport the show

Are you struggling to bridge the gap between lab-scale models and commercial bioprocessing reality? For many biotech innovators, the promise of digital twins meets harsh industrial constraints - where hybrid models that excel in controlled lab environments must prove themselves in the complexity of large-scale manufacturing.This week on the Smart Biotech Scientist Podcast, host David Brühlmann welcomes Krist Gernaey, Professor of Industrial Fermentation Technology at the Technical University of Denmark. With expertise spanning measurement technology development and two decades pioneering hybrid model digital twins for bioprocess applications, Krist reveals the critical gap between digitalization hype and industrial implementation reality.Here are three key reasons this episode will level up your hybrid modelling and digital twin approaches.From Data Overload to Intelligent Control: Raw sensor data means nothing without the right models to interpret it. Krist demonstrates how hybrid model digital twins convert complex bioprocess measurements into actionable control strategies - showing why sophisticated algorithms need simple, robust sensors to succeed at commercial scale.From Individual Genius to Team Implementation: The most elegant digital twin fails without operator buy-in. Krist shares why successful commercial bioprocessing depends on bridging academic innovation with frontline manufacturing expertise - revealing the human factors that make or break advanced modeling initiatives.From Lab Perfection to Commercial Pragmatism: Discover why the most promising hybrid modeling approaches must balance mechanistic understanding with data-driven adaptation. Krist provides a reality check on electrochemical sensors, validation challenges, and the strategic decisions that determine whether digital twins deliver commercial value or remain expensive experiments.Ready to master the art of scaling hybrid model digital twins from promising lab tools to commercial bioprocessing game-changers? Tune in to discover Krist Gernaey's battle-tested strategies for navigating the complex journey from academic innovation to industrial impact.Connect with Krist Gernaey:LinkedIn: www.linkedin.com/in/krist-gernaey-591748Website: www.orbit.dtu.dk/en/persons/krist-v-gernaeyIf you're intrigued by the evolving frontier of bioprocessing, don't miss these enlightening episodes:Episodes 85-86: Bioprocess 4.0: Integrated Continuous Biomanufacturing with Massimo MorbidelliEpisodes 153-154: The Future of Bioprocessing: Industry 4.0, Digital Twins, and Continuous Manufacturing Strategies with Tiago MatosEpisodes 05-06: Hybrid Modeling: The Key to Smarter Bioprocessing with Michael SokolovNext step:Book a free consultation to help you get started on any questions you may have about bioprocessing analytics: https://bruehlmann-consulting.com/callDevelop bioprocessing technologies better, faster, at a fraction of the cost with our 1:1 Strategy Call: The quickest and easiest way to excel biotech technology development. Book your call at https://stan.store/SmartBiotechSupport the show

rWotD Episode 2993: Luis Veiga da Cunha Welcome to random Wiki of the Day, your journey through Wikipedia's vast and varied content, one random article at a time.The random article for Monday, 14 July 2025, is Luis Veiga da Cunha.Luis Veiga da Cunha (born 1936 in Lisbon), is a Portuguese scientist, Professor at the Department of Environmental Sciences and Engineering of the NOVA University Lisbon. He graduated in Civil Engineering at the Technical University of Lisbon and he holds a PhD degree from the same university. His main professional interests are related to Environment and Natural Resources Policies and Management, with a special emphasis on Water Resources.He worked in Portugal until 1983 in teaching, research and consulting activities. During this period he was involved in numerous research projects and undertook consulting and teaching work in Portugal and in several foreign countries.Between 1971 and 1983 he was Director of the Division of Hydrology and River Hydraulics of the National Laboratory of Civil Engineering, LNEC in Lisbon, where he initiated the development of several new lines of research in the areas of water resources management and planning and of sustainable use of water resources. He was Visiting Professor at Colorado State University (Fort Collins, Colorado) for the full academic year 1975-1976.Between 1983 and 1999 Veiga da Cunha lived in Brussels where he served as Administrator of the Scientific and Environmental Affairs Division of the North Atlantic Treaty Organization. This Division was the executive arm for the programmes initiated by two Committees of the NATO Council: the Science Committee and the Committee on the Challenges of the Modern Society. The programmes of these two committees were originally intended to foster scientific, technological and environmental cooperation between the North American and the European NATO countries. Later, after the disintegration of the Soviet Union, they mainly focused on cooperation between NATO countries and the so-called partner countries in Central and Eastern Europe and the former Soviet Union. Among his responsibilities while serving at NATO, he launched and directed various programs in the area of the environment, in particular the Special Programs on “Environmental Security” and “The Science of Global Environmental Change”. Each of these areas developed into a large number of projects and about 60 books have been published based on the results.In 1999 Veiga da Cunha returned to Portugal, as a full Professor at the Nova University of Lisbon. He also became a member of the National Council on Environment and Sustainable Development since 2001 and of the National Water Council since its creation in 1994. From 2001 to 2005 he has served as the Portuguese national delegate to the NATO Science Committee.He was a member of the International Panel on Climate Change (IPCC) of the United Nations (1999-2001) and a Lead Author of the chapter on Water Resources of the Third Assessment Report of the IPCC, published in 2001. He was also author and coordinator of the chapter on Water Resources of the Portuguese National Projects SIAM I and SIAM II (Climate Change in Portugal: Scenarios, Impacts and Adaptation Measures, 2001-2006).He was founder and the first President of the Portuguese Water Resources Association (1977–78) and Director of the International Water Resources Association. He was Director of the International Water Resources Association and Chairman of the Committee on River Hydraulics of the International Association on Hydraulic Research. He has been a member of the Editorial Board of Water Policy, the official science and technology journal of the World Water Council. He has also been a member of the Editorial Board of Water International, the journal of the International Water Resources Association. From 2010 to 2013 he was a member and coordinator of the "Gulbenkian Think Thank on Water and the Future of Humanity", an international group of reflection established by the Calouste Gulbenkian Foundation that gathered eleven distinguished scientists and experts in global water issues. The book "Water and the Future of Humanity" (Springer) was published in 2014, as a result of this work. Veiga da Cunha is a member of the Portuguese Academy of Engineering and a member and of the French Water Academy.He is the author of more than one hundred publications, including about 30 books and book chapters on environmental issues and particular on water resources related topics.He was awarded the Portuguese Order of “St. James of the Sword” (Grand-Officer) for scientific and cultural merit, and the French “National Order of Merit” (Grand-Officer). He was Minister of Education of Portugal in 1979-1980.This recording reflects the Wikipedia text as of 00:24 UTC on Monday, 14 July 2025.For the full current version of the article, see Luis Veiga da Cunha on Wikipedia.This podcast uses content from Wikipedia under the Creative Commons Attribution-ShareAlike License.Visit our archives at wikioftheday.com and subscribe to stay updated on new episodes.Follow us on Mastodon at @wikioftheday@masto.ai.Also check out Curmudgeon's Corner, a current events podcast.Until next time, I'm standard Russell.

In the first part of the program, our new colleague Gigi Ann Green discusses AI with Professor Peter Drotár from the Technical University in Košice and Project Manager Viera Bordoy from the Slovak University of Technology. They share insights into the European Summer School on Artificial Intelligence, the state and potential of the AI industry in Slovakia, and what ESSAI means for the country's role in Europe's AI future. Then you will hear an interview with young developer Juraj Kollár, who won a programming competition with his own app at the age of 11. And finally, you will hear another part of our Who Was That series, this time dedicated to Ján Andrej Segner.

Vertical farming has been increasingly used for leafy greens like lettuce and kale, as well as for herbs and a few fruits like strawberries and tomatoes.  A recent study by the Technical University of Munich has investigated the use of vertical farming for a much broader range of foods.  The study looked at the positive […]

Dr. Miriam Baumgartner is a veterinarian and equine scientist with over 15 years of experience researching horse-friendly husbandry. Her work focuses on how equine behavior and health reflect their living conditions, aiming to improve welfare and sustainability in horse management.Miriam earned her doctorate in 2012 from the Ludwig Maximilian University of Munich (LMU) in the field of ethology, animal husbandry, and animal welfare, specializing in the lying behavior of horses in open housing systems. From 2013to 2017, she contributed as a researcher at the Technical University of Munich-Weihenstephan, working on the Weihenstephaner evaluation system, for which she was awarded the Boehringer-Ingelheim Animal Welfare Medal in 2015. In addition to her academic endeavors, she gained practical experience as an equine veterinarian from 2010 to 2015.Between 2018 and 2021, Miriam led the development of the BestTUPferd project, a collaborative research initiative based on her previous studies, aimed at developing an assessment system for evaluating animal welfare and environmental impacts in horse husbandry.Since 2022, she has been a senior scientist in the Equine Team at Agroscope, working at the Swiss National Stud Farm, where she continues her dedication to advancing sustainable and welfare-friendly horse management practices.  In 2025, she completed her habilitation on the topic: "Animal welfare in horse husbandry – how to measure, assess, and improve? Development of indicators for evaluating the welfare compliance of horse husbandry systems with regard to validity, reliability, and practicality as a basis for a digital advisory tool."Miriam's research output is available at this link: https://www.researchgate.net/profile/Miriam-BaumgartnerIf you would like a complete list of her publications, email us at team@changingrein.com.au

Dr. Charlotte Frenkel from the Technical University of Delft set records with a low-power neuromorphic chip she designed as part of her Ph.D. In this episode of Brains and Machines, she talks to Dr. Sunny Bains of University College London about what she has learned about building simplicity into chips and integrity into benchmarks. Discussion follows with Dr. Giulia D'Angelo from the Czech Technical University in Prague and Professor Ralph Etienne-Cummings of Johns Hopkins University.

Can science turn any blood into a universal donor type? Join us in this episode as we explore groundbreaking healthcare innovations with Maher Abou Hachem, a distinguished Professor in the Department of Biotechnology and Biomedicine at the Technical University of Denmark. Maher's expertise spans recombinant protein production, purification, biomolecular interactions, stability, and enzymology. From gut microbiome studies to pioneering blood type conversion, his cutting-edge research is reshaping the future of healthcare. Are you ready to find out what makes Maher's work so unique? Hit play to find out! Dive in now to discover: What the major blood types are, and how they are used in transfusion and transplant applications. What happens if you give the wrong blood type to a patient. How researchers can change one blood type to another. The significance of red blood cells in the human body. You can learn more about Maher and his investigations here! Episode also available on Apple Podcasts: http://apple.co/30PvU9

Send us a textThis week on Here's What We Know, Gary shares a pint (and some amazing stories) with Dan Gordon of Gordon Biersch Brewery! From a teen trip to Germany that changed his life to crafting beers for big names like Sammy Hagar, Ryan Reynolds, and Trader Joe's, Dan's journey is equal parts inspiring and entertaining.Plus, they dig into the heart of brewing, why music and beer are surprisingly connected, and how to do Oktoberfest the right way.Whether you're a craft beer enthusiast or just love a good story about pursuing your passion and inspiration, this episode is for you! Give it a listen, and maybe crack open a cold one while you do!In This Episode:How a 15-year-old's trip to Germany sparked a lifelong careerThe science behind consistent, quality beer makingWhat it's like brewing for Trader Joe's, Kirkland, Betty Buzz, and beyondHow Dan's music background shapes teamwork and creativity in businessTips for Oktoberfest (and what to eat with your beer!)This episode is sponsored by: Sterling Oak Cabinetry (Bring your dream cabinet to life!) Bio:Dan Gordon is the co-founder of Gordon Biersch and one of America's top brewing engineers. A San Jose native, Dan earned his brewing degree from the prestigious Technical University of Munich in Weihenstephan—becoming the first American in over 40 years to do so. Before that, he studied resource economics at UC Berkeley and gained hands-on experience at Anheuser-Busch and Spaten Brewery.In 1988, Dan partnered with Dean Biersch to launch their first brewery restaurant in Palo Alto, helping to pioneer the brewpub concept in California. Today, he still oversees operations in San Jose, ensuring every beer follows traditional German purity laws using premium ingredients.Beyond beer, Dan is also an accomplished jazz trombonist, performing across the Bay Area and recording with artists like Michael Davis and Curtis Campbell. Whether he's brewing lagers or laying down brass lines, Dan brings heart, discipline, and creativity to everything he does.Website: https://gordonbiersch.com/LinkedIn: https://www.linkedin.com/in/dan-gordon-6429916/Facebook: https://www.facebook.com/gordonbierschbrewingco/Instagram: https://www.instagram.com/gordonbierschbrewco/TikTok: https://www.tiktok.com/@gordonbierschbrewcoConnect with Gary: Gary's Website Follow Gary on Instagram Gary's Tiktok Gary's Facebook Watch the episodes on YouTube Advertise on the Podcast Thank you for listening. Let us know what you think about this episode. Leave us a review!

The AI EFFECT project aims to establish a European Testing and Experimentation Facility (TEF) for the energy sector to develop, test, and validate AI applications. Funded by  Horizon Europe, the project addresses the integration of AI into critical energy infrastructures to optimize operations, reduce costs, enhance resilience, and support decarbonization efforts.   This episode of the EPRI Current examines AI's role in improving efficiency, smart grids, generation, distribution, and customer tools as well as some challenges emerging from use cases such as the need for mathematical guarantees to trust AI.   For more information about AI EFFECT and AI in the power industry: AI EFFECT: AI-EFFECT | acquiacmsminimaltemplate OPEN POWER AI: Open Power AI Consortium | EPRI Micro Sites   Host:  Samantha Gilman   Guests:              Gianluca Lipari, Technical Leader - European Projects Coordinator, EPRI Massimo Bolognessi, Senior Electrical Design Engineer, ENEL Grids Johanna Vorwerk,  Assistant Professor, Wind and Energy Systems, Technical University of Denmark   If you enjoy this podcast, please subscribe and share! And please consider leaving a review and rating on Apple Podcasts/iTunes.    Follow EPRI: LinkedIn https://www.linkedin.com/company/epri/  Twitter https://twitter.com/EPRINews    EPRI Current examines key issues and new R&D impacting the energy transition. Each episode features insights from EPRI, the world's preeminent independent, non-profit energy research and development organization, and from other energy industry leaders. We also discuss how innovative technologies are shaping the global energy future. Learn more at www.epri.com       

On This Week in HPC, Addison Snell chats with the winners of the Hans Meuer Awards, Martin Schultz and Durganshu Mishra from Technical University Munich (TU-Munich). They go over their research and look forward to the upcoming ISC25.

Alina Kadluba from the Technical University of Munich (Germany) discusses the article, "How much C is in TPACK? A systematic review on the assessment of TPACK in mathematics," published in Educational Studies in Mathematics (Vol. 118). Co-authors: Anselm Strohmaier, Christian Schons, Andreas Obersteiner. Article URL: https://link.springer.com/article/10.1007/s10649-024-10357-x Alina's professional webpage List of episodes

Send us a textNikolaj Kloch shares his unique journey from aerospace engineering to becoming a leading videographer specializing in content creation for public speakers. He discusses how engineering skills translate into entrepreneurship, content creation, and business development.Main Topics:Transitioning from aerospace engineering to videographyBuilding a business by leading with valuePublic speaking tips for engineersLeveraging engineering skills in content creationSocial media and networking strategiesCareer change advice for professionalsAbout the guest: Nikolaj Kloch is a former aerospace engineer turned videographer who specializes in creating content for public speakers. With over four years of experience, he helps speakers boost their visibility, book more engagements, and increase their income—serving clients who've spoken for top companies like AWS, Jaguar, and Airbus. Previously, he worked at Boeing as a Propulsion Design Engineer and was part of the MSTEP Steering Committee. He holds engineering degrees from Georgia Tech and the Technical University of Denmark. Outside work, he's an ultramarathon runner and Eagle Scout, known for his dedication, versatility, and inspiring career journey.Links:Nikolaj Kloch - LinkedInThrivr Design Website 

In this episode of the Epigenetics Podcast, we talked with Dr. Frank Johannes from the Technical University of Munich in Freising about his work on evolutionary clocks and epigenetic inheritance in plants. In this episode we discuss Dr. Johannes pursuits in understanding how heritable epigenetic variations, particularly through DNA methylation, affect phenotypic diversity in plants. He shared insights about groundbreaking research initiatives he has led, including one of the first population epigenetic studies in plants that effectively linked heritable DNA methylation changes to critical traits like flowering time and root length. This work underscored the importance of epigenetic factors that extend beyond traditional genetic sequences, illustrating a significant shift in how we comprehend inheritance and trait variation in organisms. As we dug deeper into the science, we examined Dr. Johannes's innovative approaches to studying chromatin-based mechanisms of genome regulation, allowing for a nuanced understanding of epigenetic inheritance. His lab's extensive phenotyping of Arabidopsis plants highlighted how inducing heritable variations in DNA methylation could lead to significant trait outcomes – results that have substantial implications for agriculture and understanding complex characteristics across generations. The dialogue continued to unravel the dynamics between forward and backward epimutations, delving into their heritable nature and their rapid accumulation compared to traditional genetic mutations. Dr. Johannes overturned conventional understanding by presenting epigenetic processes that are not as static as once thought, providing compelling evidence that these spontaneous changes could inform evolutionary clocks; a concept that offers new avenues for studying the relationships between species over relatively short timeframes. Moreover, we discussed the exciting concept of epigenetic clocks, which play a role in assessing the age of various species, including trees. The potential applications for such clocks in environmental management and the assessment of tree vitality further illuminated the practical impacts of Dr. Johannes's research. These insights also pave the way for sophisticated non-invasive methods of understanding plant biology, which can revolutionize forest management practices in the face of climate change and other ecological pressures.   References Colomé-Tatché M, Cortijo S, Wardenaar R, Morgado L, Lahouze B, Sarazin A, Etcheverry M, Martin A, Feng S, Duvernois-Berthet E, Labadie K, Wincker P, Jacobsen SE, Jansen RC, Colot V, Johannes F. Features of the Arabidopsis recombination landscape resulting from the combined loss of sequence variation and DNA methylation. Proc Natl Acad Sci U S A. 2012 Oct 2;109(40):16240-5. doi: 10.1073/pnas.1212955109. Epub 2012 Sep 17. PMID: 22988127; PMCID: PMC3479620. Cortijo S, Wardenaar R, Colomé-Tatché M, Gilly A, Etcheverry M, Labadie K, Caillieux E, Hospital F, Aury JM, Wincker P, Roudier F, Jansen RC, Colot V, Johannes F. Mapping the epigenetic basis of complex traits. Science. 2014 Mar 7;343(6175):1145-8. doi: 10.1126/science.1248127. Epub 2014 Feb 6. PMID: 24505129. van der Graaf A, Wardenaar R, Neumann DA, Taudt A, Shaw RG, Jansen RC, Schmitz RJ, Colomé-Tatché M, Johannes F. Rate, spectrum, and evolutionary dynamics of spontaneous epimutations. Proc Natl Acad Sci U S A. 2015 May 26;112(21):6676-81. doi: 10.1073/pnas.1424254112. Epub 2015 May 11. PMID: 25964364; PMCID: PMC4450394. Yao N, Zhang Z, Yu L, Hazarika R, Yu C, Jang H, Smith LM, Ton J, Liu L, Stachowicz JJ, Reusch TBH, Schmitz RJ, Johannes F. An evolutionary epigenetic clock in plants. Science. 2023 Sep 29;381(6665):1440-1445. doi: 10.1126/science.adh9443. Epub 2023 Sep 28. PMID: 37769069.   Related Episodes Transgenerational Inheritance and Epigenetic Imprinting in Plants (Mary Gehring) Epigenetic Clocks and Biomarkers of Ageing (Morgan Levine)   Contact Epigenetics Podcast on Mastodon Epigenetics Podcast on Bluesky Dr. Stefan Dillinger on LinkedIn Active Motif on LinkedIn Active Motif on Bluesky Email: podcast@activemotif.com

Postprocessing is a necessary part of the additive manufacturing (AM) workflow in almost every instance, because 3D printing alone rarely yields a finished part ready for use. Depending on the materials and processes they choose, AM adopters have to account for depowdering, curing, heat treat, cleaning, dyeing, tumbling, machining and many other post-print operations. Coupled with the high-mix, low-volume production typical in AM, such steps are difficult to automate or optimize — leading many companies to develop innovative and often secretive internal processes.   In this episode of AM Radio, Stephanie Hendrixson, Peter Zelinski, Jessica Pompili and Jodee McElfresh share examples of how additive manufacturers solve their varied postprocessing challenges and seek to answer some of the questions around these critical steps.   Thanks to listeners who sent questions, left comments or lent their expertise to this episode, including Matt Havekost, Rick Beddoe, Miguel Valenzuela, Konstantin Rybalcenko, Rey Chu, John Whalen and those who responded anonymously.   Find photos, related links and the transcript for this episode on AdditiveManufacturing.Media.   This episode is brought to you by Additive Manufacturing Media. Never miss a story.    Mentioned in this episode: Our calls for questions — and discussion— around postprocessing on LinkedIn Meet Jessica Pompili, Additive Manufacturing Media assistant editor A conversation on finishing's role in AM with Products Finishing editor-in-chief Scott Francis Our story on ATI's new Florida facility Article on Rivelin's robotic machining technology from Derek Korn, editor-in-chief of sister brand Production Machining Video on how the Rivelin solution works AM-Flow's sorting solution for mixed part batches The Cool Parts Show LIVE: Special 5-Year Anniversary Episode with support removal "hatch" 3D Printed Metal Component for CNC Machining Center | The Cool Parts Show #47 with sacrificial powder removal feature Micro Factory's enclosed mSLA system The modular JENI production system from Photocentric Solvent recycling technology company CBG Biotech How metal injection molding and metal binder jetting coexist at Smith Metal Products The metal binder jetting workflow at Freeform Technologies An example of a thin-fin cold plate produced by Conflux Technology Resolution in vat photopolymerization and smoothing techniques developed at the Technical University of Denmark

Oberbrechen: A German Village Confronts Its Nazi Past (Oxford UP, 2024) is a new title in OUP's Graphic History Series that chronicles the events of the Holocaust and its aftermath in a small village in rural Germany. Based on meticulous research and using powerful visual storytelling, the book provides a multilayered narrative that explores the experiences of both Jewish and non-Jewish villagers from the First World War to the present. Its focus on how "ordinary" people experienced this time offers a new and illuminating insight into everyday life and the processes of violence, rupture, and reconciliation that characterized the history of the twentieth century in Germany and beyond. The graphic narrative is accompanied by source documents published in English translation for the first time, an essay on the wider historical context, and an incisive reflection on the writing of this book—and of history more broadly. Kim Wünschmann is Director of the Institute for the History of the German Jews and teaches at the University of Hamburg. She obtained her Ph.D. from Birkbeck, University of London. Her research centers on German Jewish history, Holocaust Studies, and legal history. She held fellowships at The Hebrew University of Jerusalem and the International Institute for Holocaust Research at Yad Vashem. She was DAAD Lecturer at the Centre for German-Jewish Studies at the University of Sussex and Research Associate at the Department of History at LMU Munich. Her Publications include Before Auschwitz: Jewish Prisoners in the Prewar Concentration Camps (Harvard University Press, 2015), awarded the Yad Vashem International Book Prize for Holocaust Research. She is also the co-editor of Living the German Revolution 1918–19: Expectations, Experiences, Responses (Oxford University Press, 2023) and together with Stefanie Fischer co-author of the Graphic History Oberbrechen: A German Village Confronts Its Nazi Past, illustrated by Liz Clarke (Oxford University Press, 2024) . Stefanie Fischer a Senior Lecturer at the Center for the Study of Antisemitism at the Technical University of Berlin. Her fields of scholarly research are German Jewish history and Holocaust Studies. Fischer is the author of Jewish Cattle Traders in the German Countryside, 1919-1939. Economic Trust and Antisemitic Violence (Indiana University Press, 2024) and with Kim Wünschmann of Oberbrechen. A German Village Confronts its Nazi Past (Oxford University Press, 2025). She is also co-editor of the Leo Baeck Institute Year Book (Oxford University Press, since 2024). Learn more about your ad choices. Visit megaphone.fm/adchoices Support our show by becoming a premium member! https://newbooksnetwork.supportingcast.fm/history

Oberbrechen: A German Village Confronts Its Nazi Past (Oxford UP, 2024) is a new title in OUP's Graphic History Series that chronicles the events of the Holocaust and its aftermath in a small village in rural Germany. Based on meticulous research and using powerful visual storytelling, the book provides a multilayered narrative that explores the experiences of both Jewish and non-Jewish villagers from the First World War to the present. Its focus on how "ordinary" people experienced this time offers a new and illuminating insight into everyday life and the processes of violence, rupture, and reconciliation that characterized the history of the twentieth century in Germany and beyond. The graphic narrative is accompanied by source documents published in English translation for the first time, an essay on the wider historical context, and an incisive reflection on the writing of this book—and of history more broadly. Kim Wünschmann is Director of the Institute for the History of the German Jews and teaches at the University of Hamburg. She obtained her Ph.D. from Birkbeck, University of London. Her research centers on German Jewish history, Holocaust Studies, and legal history. She held fellowships at The Hebrew University of Jerusalem and the International Institute for Holocaust Research at Yad Vashem. She was DAAD Lecturer at the Centre for German-Jewish Studies at the University of Sussex and Research Associate at the Department of History at LMU Munich. Her Publications include Before Auschwitz: Jewish Prisoners in the Prewar Concentration Camps (Harvard University Press, 2015), awarded the Yad Vashem International Book Prize for Holocaust Research. She is also the co-editor of Living the German Revolution 1918–19: Expectations, Experiences, Responses (Oxford University Press, 2023) and together with Stefanie Fischer co-author of the Graphic History Oberbrechen: A German Village Confronts Its Nazi Past, illustrated by Liz Clarke (Oxford University Press, 2024) . Stefanie Fischer a Senior Lecturer at the Center for the Study of Antisemitism at the Technical University of Berlin. Her fields of scholarly research are German Jewish history and Holocaust Studies. Fischer is the author of Jewish Cattle Traders in the German Countryside, 1919-1939. Economic Trust and Antisemitic Violence (Indiana University Press, 2024) and with Kim Wünschmann of Oberbrechen. A German Village Confronts its Nazi Past (Oxford University Press, 2025). She is also co-editor of the Leo Baeck Institute Year Book (Oxford University Press, since 2024). Learn more about your ad choices. Visit megaphone.fm/adchoices Support our show by becoming a premium member! https://newbooksnetwork.supportingcast.fm/jewish-studies

This episode of Plan Sea was recorded live at the Ocean Visions Biennial Summit 2025, and features conversation with Ocean Visions CEO Brad Ack and other attendees to discuss their work in ocean-based carbon dioxide removal (oCDR). Host Anna Madlener is joined by a special co-host, Danny Gawlowski, Carbon to Sea's Senior Manager of Communications and Policy.Guests on this episode include: Brad Ack, CEO of Ocean VisionsMarc von Keitz, Director at The Grantham Foundation for the Protection of the EnvironmentMariam Swaleh, Assistant Registrar of Research and Grants at Technical University of Mombasa, Team Lead at Ocean-Climate Innovation Hub Kenya, and OCI Fellow at the Global Ecosystem of Ocean SolutionsLily Schacht, Senior Carbon Removal Verification Engineer at 350SolutionsMeg Chadsey, Carbon Specialist at Washington Sea GrantPlan Sea is a semi-weekly podcast exploring ocean-based climate solutions, brought to you by the Carbon to Sea Initiative & the American University Institute for Responsible Carbon Removal.

Oberbrechen: A German Village Confronts Its Nazi Past (Oxford UP, 2024) is a new title in OUP's Graphic History Series that chronicles the events of the Holocaust and its aftermath in a small village in rural Germany. Based on meticulous research and using powerful visual storytelling, the book provides a multilayered narrative that explores the experiences of both Jewish and non-Jewish villagers from the First World War to the present. Its focus on how "ordinary" people experienced this time offers a new and illuminating insight into everyday life and the processes of violence, rupture, and reconciliation that characterized the history of the twentieth century in Germany and beyond. The graphic narrative is accompanied by source documents published in English translation for the first time, an essay on the wider historical context, and an incisive reflection on the writing of this book—and of history more broadly. Kim Wünschmann is Director of the Institute for the History of the German Jews and teaches at the University of Hamburg. She obtained her Ph.D. from Birkbeck, University of London. Her research centers on German Jewish history, Holocaust Studies, and legal history. She held fellowships at The Hebrew University of Jerusalem and the International Institute for Holocaust Research at Yad Vashem. She was DAAD Lecturer at the Centre for German-Jewish Studies at the University of Sussex and Research Associate at the Department of History at LMU Munich. Her Publications include Before Auschwitz: Jewish Prisoners in the Prewar Concentration Camps (Harvard University Press, 2015), awarded the Yad Vashem International Book Prize for Holocaust Research. She is also the co-editor of Living the German Revolution 1918–19: Expectations, Experiences, Responses (Oxford University Press, 2023) and together with Stefanie Fischer co-author of the Graphic History Oberbrechen: A German Village Confronts Its Nazi Past, illustrated by Liz Clarke (Oxford University Press, 2024) . Stefanie Fischer a Senior Lecturer at the Center for the Study of Antisemitism at the Technical University of Berlin. Her fields of scholarly research are German Jewish history and Holocaust Studies. Fischer is the author of Jewish Cattle Traders in the German Countryside, 1919-1939. Economic Trust and Antisemitic Violence (Indiana University Press, 2024) and with Kim Wünschmann of Oberbrechen. A German Village Confronts its Nazi Past (Oxford University Press, 2025). She is also co-editor of the Leo Baeck Institute Year Book (Oxford University Press, since 2024). Learn more about your ad choices. Visit megaphone.fm/adchoices Support our show by becoming a premium member! https://newbooksnetwork.supportingcast.fm/european-studies

Oberbrechen: A German Village Confronts Its Nazi Past (Oxford UP, 2024) is a new title in OUP's Graphic History Series that chronicles the events of the Holocaust and its aftermath in a small village in rural Germany. Based on meticulous research and using powerful visual storytelling, the book provides a multilayered narrative that explores the experiences of both Jewish and non-Jewish villagers from the First World War to the present. Its focus on how "ordinary" people experienced this time offers a new and illuminating insight into everyday life and the processes of violence, rupture, and reconciliation that characterized the history of the twentieth century in Germany and beyond. The graphic narrative is accompanied by source documents published in English translation for the first time, an essay on the wider historical context, and an incisive reflection on the writing of this book—and of history more broadly. Kim Wünschmann is Director of the Institute for the History of the German Jews and teaches at the University of Hamburg. She obtained her Ph.D. from Birkbeck, University of London. Her research centers on German Jewish history, Holocaust Studies, and legal history. She held fellowships at The Hebrew University of Jerusalem and the International Institute for Holocaust Research at Yad Vashem. She was DAAD Lecturer at the Centre for German-Jewish Studies at the University of Sussex and Research Associate at the Department of History at LMU Munich. Her Publications include Before Auschwitz: Jewish Prisoners in the Prewar Concentration Camps (Harvard University Press, 2015), awarded the Yad Vashem International Book Prize for Holocaust Research. She is also the co-editor of Living the German Revolution 1918–19: Expectations, Experiences, Responses (Oxford University Press, 2023) and together with Stefanie Fischer co-author of the Graphic History Oberbrechen: A German Village Confronts Its Nazi Past, illustrated by Liz Clarke (Oxford University Press, 2024) . Stefanie Fischer a Senior Lecturer at the Center for the Study of Antisemitism at the Technical University of Berlin. Her fields of scholarly research are German Jewish history and Holocaust Studies. Fischer is the author of Jewish Cattle Traders in the German Countryside, 1919-1939. Economic Trust and Antisemitic Violence (Indiana University Press, 2024) and with Kim Wünschmann of Oberbrechen. A German Village Confronts its Nazi Past (Oxford University Press, 2025). She is also co-editor of the Leo Baeck Institute Year Book (Oxford University Press, since 2024). Learn more about your ad choices. Visit megaphone.fm/adchoices Support our show by becoming a premium member! https://newbooksnetwork.supportingcast.fm/new-books-network

Oberbrechen: A German Village Confronts Its Nazi Past (Oxford UP, 2024) is a new title in OUP's Graphic History Series that chronicles the events of the Holocaust and its aftermath in a small village in rural Germany. Based on meticulous research and using powerful visual storytelling, the book provides a multilayered narrative that explores the experiences of both Jewish and non-Jewish villagers from the First World War to the present. Its focus on how "ordinary" people experienced this time offers a new and illuminating insight into everyday life and the processes of violence, rupture, and reconciliation that characterized the history of the twentieth century in Germany and beyond. The graphic narrative is accompanied by source documents published in English translation for the first time, an essay on the wider historical context, and an incisive reflection on the writing of this book—and of history more broadly. Kim Wünschmann is Director of the Institute for the History of the German Jews and teaches at the University of Hamburg. She obtained her Ph.D. from Birkbeck, University of London. Her research centers on German Jewish history, Holocaust Studies, and legal history. She held fellowships at The Hebrew University of Jerusalem and the International Institute for Holocaust Research at Yad Vashem. She was DAAD Lecturer at the Centre for German-Jewish Studies at the University of Sussex and Research Associate at the Department of History at LMU Munich. Her Publications include Before Auschwitz: Jewish Prisoners in the Prewar Concentration Camps (Harvard University Press, 2015), awarded the Yad Vashem International Book Prize for Holocaust Research. She is also the co-editor of Living the German Revolution 1918–19: Expectations, Experiences, Responses (Oxford University Press, 2023) and together with Stefanie Fischer co-author of the Graphic History Oberbrechen: A German Village Confronts Its Nazi Past, illustrated by Liz Clarke (Oxford University Press, 2024) . Stefanie Fischer a Senior Lecturer at the Center for the Study of Antisemitism at the Technical University of Berlin. Her fields of scholarly research are German Jewish history and Holocaust Studies. Fischer is the author of Jewish Cattle Traders in the German Countryside, 1919-1939. Economic Trust and Antisemitic Violence (Indiana University Press, 2024) and with Kim Wünschmann of Oberbrechen. A German Village Confronts its Nazi Past (Oxford University Press, 2025). She is also co-editor of the Leo Baeck Institute Year Book (Oxford University Press, since 2024). Learn more about your ad choices. Visit megaphone.fm/adchoices Support our show by becoming a premium member! https://newbooksnetwork.supportingcast.fm/german-studies

Oberbrechen: A German Village Confronts Its Nazi Past (Oxford UP, 2024) is a new title in OUP's Graphic History Series that chronicles the events of the Holocaust and its aftermath in a small village in rural Germany. Based on meticulous research and using powerful visual storytelling, the book provides a multilayered narrative that explores the experiences of both Jewish and non-Jewish villagers from the First World War to the present. Its focus on how "ordinary" people experienced this time offers a new and illuminating insight into everyday life and the processes of violence, rupture, and reconciliation that characterized the history of the twentieth century in Germany and beyond. The graphic narrative is accompanied by source documents published in English translation for the first time, an essay on the wider historical context, and an incisive reflection on the writing of this book—and of history more broadly. Kim Wünschmann is Director of the Institute for the History of the German Jews and teaches at the University of Hamburg. She obtained her Ph.D. from Birkbeck, University of London. Her research centers on German Jewish history, Holocaust Studies, and legal history. She held fellowships at The Hebrew University of Jerusalem and the International Institute for Holocaust Research at Yad Vashem. She was DAAD Lecturer at the Centre for German-Jewish Studies at the University of Sussex and Research Associate at the Department of History at LMU Munich. Her Publications include Before Auschwitz: Jewish Prisoners in the Prewar Concentration Camps (Harvard University Press, 2015), awarded the Yad Vashem International Book Prize for Holocaust Research. She is also the co-editor of Living the German Revolution 1918–19: Expectations, Experiences, Responses (Oxford University Press, 2023) and together with Stefanie Fischer co-author of the Graphic History Oberbrechen: A German Village Confronts Its Nazi Past, illustrated by Liz Clarke (Oxford University Press, 2024) . Stefanie Fischer a Senior Lecturer at the Center for the Study of Antisemitism at the Technical University of Berlin. Her fields of scholarly research are German Jewish history and Holocaust Studies. Fischer is the author of Jewish Cattle Traders in the German Countryside, 1919-1939. Economic Trust and Antisemitic Violence (Indiana University Press, 2024) and with Kim Wünschmann of Oberbrechen. A German Village Confronts its Nazi Past (Oxford University Press, 2025). She is also co-editor of the Leo Baeck Institute Year Book (Oxford University Press, since 2024). Learn more about your ad choices. Visit megaphone.fm/adchoices Support our show by becoming a premium member! https://newbooksnetwork.supportingcast.fm/genocide-studies

Dominique de Werra is an emeritus professor of Operations Research at EPFL (Ecole Polytechnique Federale de Lausanne) in Switzerland. His research fields include Combinatorial Optimization, Graph Theory, Scheduling and Timetabling. After spending a few years as an assistant professor in Management Sciences at the University of Waterloo (Canada) he joined the Math Department of EPFL. He conducted a collection of Operational Research projects (applied as well as theoretical) with a number of industrial partners. He is an associate editor of Discrete Applied Mathematics, Discrete Mathematics, Annals of Operations Research and a member of a dozen of editorial boards of international journals. From 1990 to 2000 Dominique de Werra was the Vice-President of EPFL; he was in charge of the international relations and represented his institution in many academy networks in Europe (like the CLUSTER network of excellence which he chaired). He was also in charge of all education programs of EPFL. He was President of IFORS (the International Federation of Operational Research Societies) from 2010 to 2012. In 1987-1988 he was President of EURO, the European Association of Operational Research Societies. In 1985–1986 he was President of ASRO, the Swiss Operations Research Society. In 1995 he was the laureate of the EURO Gold Medal. He has obtained Honorary Degrees from the University of Paris, the Technical University of Poznan (Poland) and the University of Fribourg (Switzerland). In 2012 he was awarded the EURO Distinguished Service Medal. He published over 200 papers in international scientific journals. He also wrote and edited several books. He was member of many committees in various countries of Europe and America (evaluation of institutions, accreditation, strategic orientation, etc.).

In this episode, we sit down with Bam Azizi, the CEO and Co-Founder of Mesh—a fintech infrastructure company revolutionizing how businesses and users interact with financial systems through embedded crypto and stablecoin solution with 300+ integrations today. Mesh empowers developers to seamlessly enable read, write, and transfer functionality within their applications. They recently closed an $82M Series B round, primarily settled in stablecoins, reflecting the company's core mission of making digital money programmable and practical.Before Mesh, Bam Azizi co-founded NoPassword, a pioneering identity company acquired by LogMeIn, where he later served as Director. He brings over a decade of experience in software architecture, cybersecurity, and AI, including roles at Infineon Technologies and Robotic Research Labs. A visiting researcher at Johns Hopkins University and PhD holder from Technical University of Munich, Bamizi combines deep technical expertise with visionary entrepreneurship.LinkedIn: https://www.linkedin.com/in/bam-azizi-54117310aMesh LinkedIn: https://www.linkedin.com/company/meshconnectapi/Website: https://www.meshconnect.com/

Today, we're tackling a topic that has become increasingly vital in recent years: supply chain management.  With global supply chains recently under immense pressure from disruptions, shortages, and growing complexity, the need for smarter, more efficient solutions has never been greater.  And what better way to explore this than by discussing the cutting-edge role of AI-powered supply chain management software. Mike Konrad's guest is Sebastian Schaal, the founder and CEO of Luminovo, a company at the forefront of transforming how supply chains are managed in the electronics industry. Sebastian Schaal is the founder of Luminovo, a leading software provider revolutionizing the electronics supply chain.  He holds two master's degrees—one in electrical and computer engineering from the Technical University of Munich and another from Stanford University, where he was a Fulbright scholar focusing on management and computer science.  Before founding Luminovo, Schaal gained diverse industry experience, working on AI algorithms for signal processing and computer vision at Intel and robotics companies NavVis and Magazino.  Additionally, he served as a consultant at McKinsey, advising on data strategy. Sebastian and his team are leveraging artificial intelligence to streamline processes, enhance collaboration, and future-proof supply chain operations.  In this episode, we'll explore how AI is reshaping supply chain management, the unique challenges facing the electronics industry, and what companies can do to stay ahead in an ever-changing global landscape.  This conversation is packed with insights you won't want to miss. So, sit back, relax, and get ready to learn about the innovations that are revolutionizing supply chains worldwide. 

Today, we're tackling a topic that has become increasingly vital in recent years: supply chain management. With global supply chains recently under immense pressure from disruptions, shortages, and growing complexity, the need for smarter, more efficient solutions has never been greater. And what better way to explore this than by discussing the cutting-edge role of AI-powered supply chain management software.My guest today is Sebastian Schaal, the founder and CEO of Luminovo, a company at the forefront of transforming how supply chains are managed in the electronics industry. Sebastian Schaal is the founder of Luminovo, a leading software provider revolutionizing the electronics supply chain. He holds two masters degrees—one in Electrical and Computer Engineering from the Technical University of Munich and another from Stanford University, where he was a Fulbright scholar focusing on Management and Computer Science. Before founding Luminovo, Sebastian gained diverse industry experience, working on AI algorithms for signal processing and computer vision at Intel and robotics companies NavVis and Magazino. Additionally, he served as a consultant at McKinsey, advising on data strategy.Sebastian and his team are leveraging artificial intelligence to streamline processes, enhance collaboration, and future-proof supply chain operations. In this episode, we'll explore how AI is reshaping supply chain management, the unique challenges facing the electronics industry, and what companies can do to stay ahead in an ever-changing global landscape. This conversation is packed with insights you won't want to miss.So, sit back, relax, and get ready to learn about the innovations that are revolutionizing supply chains worldwide. Luminovohttps://luminovo.com

I was fascinated to speak with Ada Witczyk, who does a niche thing - contemporary music on a baroque instrument - and who has enrolled an entire community in her vision!  Ada Witczyk is the fearless champion of contemporary music for baroque violin. Described as 'the new wave wizard' (South West Londoner), Ada Witczyk has inspired over 200 new works for baroque violin and counting. Singled out by BBC Music Magazine as their 'Instrumental Choice' and receiving a 10-star review, the 2023-24 season also marked the release of her album of contemporary music 'New Baroque' on First Hand Records (available on all platforms).  The 2024-25 season sees Ada perform and visit the Technical University of the Shannon in Limerick, Ireland as a guest lecturer during their online music video production series "The Millennium Sessions". She releases her second album "New Baroque-Sonatas" on First Hand Records and performs a programme filled with exciting contemporary pieces on baroque instruments at the Limerick Early Music Festival. Ada's new album is available this month! Follow her at her website, Instagram, YouTube, and Spotify!    Thanks for joining me on Crushing Classical!  Theme music and audio editing by DreamVance. You can join my email list HERE, so you never miss an episode! I help people to lean into their creative careers and start or grow their income streams.  You can read more or hop onto a short discovery call from my website. I'm your host, Jennet Ingle. I love you all. Stay safe out there!      

Andreas Imhoff, MD, Director of the Orthopaedic Sportsmedicine Department at Adam Vital Hospital Dubai and the Scientific Advisor at Sportsclinic Ravensburg, as well as Professor Emeritus of Orthopedic Surgery and Arthroscopy and Past Chair of the Department of Orthopedic Sports Medicine at the Technical University of Munich, shares about changing technologies in arthroscopy, the founding of ISAKOS, his tips for staying healthy, and more.

How can empathy and relentless determination reshape your approach to overcoming personal and professional challenges? In this episode of the Real Estate Excellence Podcast, Tracy Hayes sits down with Veronica Barba, an extraordinary real estate agent from ERA One Team Realty. From her humble beginnings in Moldova under Soviet rule to her thriving career in Jacksonville, Florida, Veronica shares an awe-inspiring story of resilience, adaptability, and passion. Having moved to the U.S. with limited English skills, Veronica turned her challenges into opportunities by embracing a client-focused approach that combines deep market knowledge, unyielding dedication, and authentic care. Veronica was born in the Republic of Moldova at that time part of Soviet Union. At 18 started to work as a nurse at Oncological Institute then later decided to change the carrier and graduated from Technical University of Moldova with a bachelor degree in Interior Design, licensed engineer and Master Degree in Architecture and Construction. In 6 years, she was working as University Lecturer at Technical University of Moldova. 9 years ago, she moved directly to Jacksonville with less than 100 words in English, no family or friends in Jacksonville and now she's 8 years of real estate journey. So far, her most successful year is 2024 with 45 closed homes.Enjoyed this episode? Share your thoughts on how empathy has played a role in your personal or professional life.   Highlights 00:01 - 04:03 Veronica Barba: Leading with the Heart ·       Growing up in Moldova during Soviet control ·       The challenges of limited freedoms and access to opportunities ·       The dream of exploring life beyond Moldova's borders ·       Studying abroad in Romania as a life-changing milestone ·       Family values and resilience in difficult societal conditions 04:04 - 21:04 Breaking into Real Estate: A Pivotal Encounter ·       How a persistent mentor introduced her to real estate ·       Overcoming doubts about her abilities in sales ·       Navigating the complexities of real estate licensure ·       The importance of finding purpose in her career choice ·       Her first steps toward mastering the real estate profession 21:05 - 34:12 Mastering the Real Estate Business ·       Learning the technical side of contracts and legalities ·       Gaining deep market knowledge through research ·       Finding creative solutions for first-time homebuyers ·       Understanding the mortgage process to better assist clients ·       Strategies for winning in competitive, multiple-offer situations   34:13 - 56:00 Heartfelt Stories: Making Dreams Come True ·       Helping an 81-year-old buy his first home ·       Going above and beyond to show the perfect property ·       Building lifelong client relationships through care and trust ·       Handling setbacks with determination and grace ·       The rewarding moments that fuel her passion for real estate   56:01 - 01:20:04 Advice for Aspiring and Experienced Agents ·       The importance of confidence, care, and authenticity ·       Leveraging past client relationships for referrals ·       How preparation and research create client trust ·       Staying adaptable in fluctuating market conditions ·       Continuous improvement as the cornerstone of success   Quotes: "I may do this every day, but for them, it's their first experience, and I have to be there for them." – Veronica Barba "If you look at life like a puzzle, finding solutions becomes a fulfilling mission." – Veronica Barba "Confidence and care—these are the foundations of building trust with clients." – Veronica Barba   To contact Veronica Barba, learn more about her business, and make her a part of your network, make sure to follow her on LinkedIn, Instagram, and Facebook. LinkedIn: https://www.linkedin.com/in/veronica-barba-07720573/ Instagram: https://www.instagram.com/veronica_barba_realtor/ Facebook: https://www.facebook.com/VeronicaBarbaRealtor/   If you want to build your business and become more discoverable online, Streamlined Media has you covered. Check out how they can help you build an evergreen revenue generator all powered by content creation!   SUBSCRIBE & LEAVE A 5-STAR REVIEW as we discuss real estate excellence with the best of the best.   #RealEstateExcellence #RealEstateJourney #GritAndSuccess #LeadingWithHeart #RealEstatePodcast #JacksonvilleHomes #MoldovanToAmericanDream #ClientFocused #EmpathyInBusiness #RealEstateAgentTips #OvercomingChallenges #RealEstateSuccess #ERARealty #RealEstateStrategies #FirstTimeHomeBuyers #RealEstateStories #PassionForRealEstate #InspiringJourneys #AmericanDream #BuildingConnections

Scientific Sense ® by Gill Eapen: Prof. Dirk Schulze-Makuch, Professor for planetary habitability and astrobiology at the Technical University, Berlin, Germany. His research interests include extra-terrestrial life. Please subscribe to this channel: https://www.youtube.com/c/ScientificSense?sub_confirmation=1

Stefan bolleininger will share with us information regarding Artificial intelligence and MDR.  This presentation happened during Medica 2024. So if you have any questions you can ask ok the comments. Who is Stefan Bolleininger?   Stefan Bolleininger is a key opinion leader and speaker for the medical device regulation MDR in Europe. He founded the be-on-Quality GmbH consulting agency to passionately support manufacturers during CE approvals or FDA approvals. This support covers the full chain of quality and regulatory requirements: Implementation, maintenance, audits, assessments, and inspections. In the area of “Risk Management and Usability for Medical Devices and Medical Networks”, he holds a teaching assignment at the Technical University of Nuremberg and the VDI Technical Committee “Quality Assurance for Software in Medical Devices”. Link  Stefan bolleininger LinkedIn: https://www.linkedin.com/in/stefan-bolleininger-3a717028/ Social Media to follow Monir El Azzouzi Linkedin: https://linkedin.com/in/melazzouzi Twitter: https://twitter.com/elazzouzim Pinterest: https://www.pinterest.com/easymedicaldevice Instagram: https://www.instagram.com/easymedicaldevice

Dr. Joe Kiniry (Mike's big brother) - is a Principal Scientist at a Portland, Oregon-based technology company called Galois. He’s also the Principled CEO and Chief Scientist of a Galois spin-out company called Free & Fair that works on high-assurance election technologies and services. Prior to joining Galois in 2014, Joe was a Full Professor at the Technical University of Denmark where he headed up the Software Engineering section. He also held a guest appointment at the IT University of Copenhagen, and has held permanent positions at four universities in Denmark, Ireland, and The Netherlands. Joe holds five advanced degrees, including a Ph.D. from Caltech.See omnystudio.com/listener for privacy information.

What the dinosaurs left behind tells the story of their rise to dominanceBones aren't the only thing we can use to understand the dinosaurs. A new study of a rich trove of fossilized feces and vomit is telling the story of how dinosaurs diversified and came to dominate the planet starting 230 million years ago. Paleontologist Martin Qvarnström from Uppsala University in Sweden said it appears that the secret to dinosaurs' success is in their ability to adapt to their changing environment. Their research is published in the journal Nature. A new kind of ‘walking' shorts could help with mobilityScientists have incorporated artificial tendons and electric motors into shorts to provide support and assistance to the hip flexor muscles that are critical for walking. In both young and old people the shorts improved performance and so could make a difference for those whose mobility has been compromised. Enrica Tricomi, a visiting researcher at the Technical University of Munich, co-developed this prototype. The study was published in the journal Nature.Shining a bright light on a new way to discourage shark attacksSharks attacks on humans are often a result of mistaken identity, when they mistake a swimming human or a surfboard for a seal or sea lion. Researchers have found that a bright patterns of LED lights can break up the visual pattern of a swimmer so that they look less like a shark's usual prey. Dr. Lucille Chapuis was part of the team that tested various patterns of lights in Seal Island, South Africa. Their research was published in Current Biology.Different species of humans walked side-by-side in Africa millions of years agoPreserved footprints near a lakeshore in Kenya show that two species of early humans, Homo erectus and Paranthropus boisei, shared the same watering hole 1.5 million years ago. This is the first direct evidence of two species of hominids sharing the same space at the same time.Dr. Kevin Hatala, professor of Biology at Chatham University, and his team's findings are in the journal Science. We no longer know how to make humans live longer – only betterHuman lifespan lengthened amazingly in the 20th century, thanks to reductions in infant mortality, improvements in public health, and successes against infectious disease. But according to a new study by S. Jay Olshansky, those gains have started to flatline in recent years. By looking at the countries with the longest lifespans, Olshansky and his colleagues found that we have traded childhood diseases for age-related diseases like cancers and Alzheimer's, and so we shouldn't expect to make many more gains in human lifespan using our current methods. Instead, he says, we should focus on improving the quality of the extra years we've gained so far. His work was published in the journal Nature Aging.We also speak with William Mair, a Professor of Molecular Metabolism at the Harvard School of Public Health. He is part of a new field of study called Geroscience, which looks at slowing down the process of aging as a whole. In his lab he has been able to extend the lifespan of simpler creatures like nematode worms and mice, and says while we have no proof we can extend a human's maximum lifespan at this time, that doesn't mean it won't be possible in the future.